Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
02/09/2011 | CN1726914B Slow release tablet of rotundine and production process |
02/09/2011 | CN1547464B Prolonged release bioadhesive therapeutic systems |
02/09/2011 | CN101970458A Novel gamma-secretase inhibitor |
02/09/2011 | CN101970438A Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidine derivatives and their medical use |
02/09/2011 | CN101970436A Azaindole compounds for treatment of central nervous system disorders |
02/09/2011 | CN101970433A Gamma secretase modulators |
02/09/2011 | CN101970431A Substituted piperidines as therapeutic compounds |
02/09/2011 | CN101970429A 2-amino-quinoline derivatives useful as inhibitors of beta-secretase (bace) |
02/09/2011 | CN101970428A Carboxamide compounds and their use as calpain inhibitors |
02/09/2011 | CN101970422A Polymorphic form of rotigotine |
02/09/2011 | CN101970408A 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine |
02/09/2011 | CN101970005A Breaking immunological tolerance with a genetically encoded unnatural amino acid |
02/09/2011 | CN101969989A Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders |
02/09/2011 | CN101969979A Apoaequorin-containing compositions and methods of using same |
02/09/2011 | CN101969965A Fertilized egg isolate and use thereof |
02/09/2011 | CN101969953A Pterin analog for treating bh4 responsive condition |
02/09/2011 | CN101969952A Methods of using and compositions comprising tryptophan hydroxylase inhibitors |
02/09/2011 | CN101969948A Kit, composition, product or medicament for treating cognitive impairment |
02/09/2011 | CN101967186A Encephalitis virus protein and code gene and application thereof |
02/09/2011 | CN101967185A Encephalitis virus protein as well as coding gene and application thereof |
02/09/2011 | CN101967169A 9-(4-beta-D- allopyranosyloxy-phenyl)-decahydroacridine-1,8-diketone as well as preparation method and application thereof |
02/09/2011 | CN101967168A Triterpenoid saponin derivative and preparation method and application thereof |
02/09/2011 | CN101967150A Spiroheterocyclic compounds and their uses as therapeutic agents |
02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
02/09/2011 | CN101967143A Ligands for G-protein coupled receptors |
02/09/2011 | CN101967117A Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
02/09/2011 | CN101966309A Traditional Chinese medicine for treating diabetes limb necrosis |
02/09/2011 | CN101966302A Chinese medicinal preparation for treating neurodermatitis |
02/09/2011 | CN101966298A Traditional Chinese medicine for treating wind-cold numbness |
02/09/2011 | CN101966292A Sugarless Chinese medicinal oral liquid and preparation method thereof |
02/09/2011 | CN101966290A Medicament for treating neurasthenia and preparation method thereof |
02/09/2011 | CN101966281A Traditional Chinese medicine for treating diabetic stomach paralysis |
02/09/2011 | CN101966266A Chinese medicinal herb health-care pad for postoperative care |
02/09/2011 | CN101966260A Chinese medicinal capsules for treating limb numbness and pain of diabetic concurrent peripheral neuropathy |
02/09/2011 | CN101966253A Tao hong si wu granule and preparation method thereof |
02/09/2011 | CN101966235A Medicament for treating migraine and preparation method thereof |
02/09/2011 | CN101966223A Fingerprint detection method for compound wintercreeper preparation |
02/09/2011 | CN101966210A Folium llicis latifoliae total glycoside and preparation method thereof |
02/09/2011 | CN101966208A Medicament for treating tristimania and preparation method thereof |
02/09/2011 | CN101966199A Application of campanumoea polysaccharide in preparation of medicament and health care food |
02/09/2011 | CN101966194A New application of scutellarin and derivatives thereof |
02/09/2011 | CN101966193A Application of 2,3,5,4-tetrahydroxystilbene-2-O-beta-D-glucoside to preparing medicaments for treating depression |
02/09/2011 | CN101966182A Compound brain protection preparation and preparation method thereof |
02/09/2011 | CN101966181A Oral solid preparation containing candesartan and amlodipine and new application thereof |
02/09/2011 | CN101966172A New purpose of caffeic acid and derivatives thereof |
02/09/2011 | CN101966167A Melatonin soft capsules and preparation method thereof |
02/09/2011 | CN101966151A Trimipramine maleate liposome solid preparation |
02/09/2011 | CN101966146A Medicinal composition solution and preparation method and use thereof |
02/09/2011 | CN101966050A Blood pressure-regulating and sleep-promoting pillow core |
02/09/2011 | CN101965974A Compositions and products containing enantiomeric equol, and methods for their making |
02/09/2011 | CN101606916B Pharmaceutical formulations of modafinil and its uses |
02/09/2011 | CN101518636B Drug for treating long-standing headache and preparation method thereof |
02/09/2011 | CN101518188B Seed reproduction and planting method of Valeriana officinalis L. |
02/09/2011 | CN101485820B Health-care bolus for persons in middle and old age |
02/09/2011 | CN101468154B Chinese medicine preparation for promoting blood circulation, activating collaterals of hemiplegia patient |
02/09/2011 | CN101468153B Analgesia Chinese medicine preparation for treating head wind |
02/09/2011 | CN101444592B Lily qingkailing preparation and preparation method thereof |
02/09/2011 | CN101406631B Medicament for treating hyperkinetic symptom of children |
02/09/2011 | CN101371872B Method for producing hard capsule using Acanthopanax senticosus and schisandra chinensis |
02/09/2011 | CN101322830B Medicament for treating postpartum depression and preparation method thereof |
02/09/2011 | CN101292960B Sustained-release microsphere containing risperidone and preparation method thereof |
02/09/2011 | CN101274063B External plaster for curing facial nerve paralysis and method of preparing the same |
02/09/2011 | CN101272793B Sphingomyelin-containing medicine, food and drink or fodder |
02/09/2011 | CN101181348B Chinese medicine prescription for applying headache and method for preparing the same |
02/09/2011 | CN101181315B New purpose of Yulangsan polysaccharide |
02/09/2011 | CN101076339B Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neurodegenerative disorders |
02/09/2011 | CN101020044B Regulating and controlling effect of thymine DNA glycosylase on signal transducing path |
02/08/2011 | USRE42126 system for delivering oral care substance to oral cavity comprising a removable backing strip having sufficient flexibility to be conformable to oral surface and oral care composition that forms film when applied to backing strip comprising organosiloxane resin, rheology modifier, and oral care substance |
02/08/2011 | US7884204 Phenylalanine derivatives |
02/08/2011 | US7884133 cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentylphenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, antiinflammatory and antidiarrheal agents |
02/08/2011 | US7884072 produce more stem cells in vivo or in vitro by culture, for transplantation into patient; increase neurogenesis or new olfactory neuron numbers; stroke, neurodegenerative disease of Alzheimer's disease, multiple sclerosis, Huntington's disease, amyotrophic lateral sclerosis, and Parkinson's disease |
02/08/2011 | US7884069 Administering hematopoietic factor; Granulocyte-colony stimulating factor, granulocyte- macrophage CSF (GM-CSF), interleukin-3 (IL-3), and IL-5; neuralogical conditions, ischemia or hypoxia, depression |
02/08/2011 | US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
02/08/2011 | US7883880 DNA polymerase lambda and uses thereof |
02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
02/08/2011 | US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
02/08/2011 | CA2639651C Orally administered peptides to ameliorate atherosclerosis |
02/08/2011 | CA2605899C Triazole derivatives as vasopressin antagonists |
02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
02/08/2011 | CA2442319C Carboxylic acid derivative and salt thereof |
02/08/2011 | CA2439117C Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide |
02/08/2011 | CA2401424C Alprazolam inclusion complexes and pharmaceutical compositions thereof |
02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
02/03/2011 | WO2011014693A2 Bacteriophages expressing amyloid peptides and uses thereof |
02/03/2011 | WO2011014679A1 Method and kit for treating nicotine addiction |
02/03/2011 | WO2011014613A2 Preparation of fipamezole |
02/03/2011 | WO2011014475A2 Treating negative symptoms of schizophrenia associated with defective neuregulin 1 |
02/03/2011 | WO2011014098A1 Hydrogenated pyrido[4,3-b]indole derivatives, pharmaceutical composition and methods for the production and use thereof |
02/03/2011 | WO2011014003A2 (+)-3-hydroxymorphinan derivatives as neuroprotectants |
02/03/2011 | WO2011013806A1 Method for production of progenitor schwann cells, and method for proliferation of progenitor schwann cells |
02/03/2011 | WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
02/03/2011 | WO2011013700A1 Carrier peptide fragment and use thereof |
02/03/2011 | WO2011013699A1 Carrier peptide fragment and use thereof |
02/03/2011 | WO2011013646A1 Pharmaceutical product for prevention and treatment of amyotrophic lateral sclerosis |
02/03/2011 | WO2011013470A1 Autoantibody production inhibitor |
02/03/2011 | WO2011012722A1 Prodrugs containing an aromatic amine connected by an amido bond to a linker |
02/03/2011 | WO2011012721A1 Carrier linked pramipexole prodrugs |
02/03/2011 | WO2011012654A1 Hydroxyasenapine compounds, derivatives thereof and pharmaceutical compositions comprising same |
02/03/2011 | WO2011012622A1 Benzoxazinone derivatives for the treatment of glytl mediated disorders |
02/03/2011 | WO2011012534A1 Plk inhibitor salts |